nodes	percent_of_prediction	percent_of_DWPC	metapath
Levonorgestrel—Hydrocortisone—Mometasone—systemic scleroderma	0.205	0.322	CrCrCtD
Levonorgestrel—Danazol—Prednisone—systemic scleroderma	0.187	0.294	CrCrCtD
Levonorgestrel—Methyltestosterone—Prednisone—systemic scleroderma	0.134	0.21	CrCrCtD
Levonorgestrel—Hydrocortisone—Prednisone—systemic scleroderma	0.112	0.175	CrCrCtD
Levonorgestrel—PGR—artery—systemic scleroderma	0.00272	0.146	CbGeAlD
Levonorgestrel—Danazol—CCL2—systemic scleroderma	0.00255	1	CrCbGaD
Levonorgestrel—PGR—blood vessel—systemic scleroderma	0.00212	0.113	CbGeAlD
Levonorgestrel—ESR1—blood vessel—systemic scleroderma	0.00166	0.0887	CbGeAlD
Levonorgestrel—SHBG—connective tissue—systemic scleroderma	0.00121	0.0645	CbGeAlD
Levonorgestrel—PGR—connective tissue—systemic scleroderma	0.00109	0.0581	CbGeAlD
Levonorgestrel—PGR—smooth muscle tissue—systemic scleroderma	0.000995	0.0532	CbGeAlD
Levonorgestrel—CYP19A1—connective tissue—systemic scleroderma	0.000978	0.0523	CbGeAlD
Levonorgestrel—AR—connective tissue—systemic scleroderma	0.000866	0.0463	CbGeAlD
Levonorgestrel—ESR1—connective tissue—systemic scleroderma	0.00085	0.0455	CbGeAlD
Levonorgestrel—AR—smooth muscle tissue—systemic scleroderma	0.000792	0.0424	CbGeAlD
Levonorgestrel—AR—skin of body—systemic scleroderma	0.000782	0.0418	CbGeAlD
Levonorgestrel—ESR1—smooth muscle tissue—systemic scleroderma	0.000778	0.0416	CbGeAlD
Levonorgestrel—PGR—lung—systemic scleroderma	0.000656	0.0351	CbGeAlD
Levonorgestrel—AR—digestive system—systemic scleroderma	0.000626	0.0334	CbGeAlD
Levonorgestrel—ESR1—digestive system—systemic scleroderma	0.000614	0.0328	CbGeAlD
Levonorgestrel—AR—tendon—systemic scleroderma	0.000595	0.0318	CbGeAlD
Levonorgestrel—AR—lung—systemic scleroderma	0.000522	0.0279	CbGeAlD
Levonorgestrel—ESR1—lung—systemic scleroderma	0.000513	0.0274	CbGeAlD
Levonorgestrel—CYP3A4—digestive system—systemic scleroderma	0.000343	0.0183	CbGeAlD
Levonorgestrel—Vomiting—Mometasone—systemic scleroderma	0.000293	0.000858	CcSEcCtD
Levonorgestrel—Sweating increased—Prednisone—systemic scleroderma	0.000291	0.000854	CcSEcCtD
Levonorgestrel—Rash—Mometasone—systemic scleroderma	0.00029	0.000851	CcSEcCtD
Levonorgestrel—Asthenia—Captopril—systemic scleroderma	0.00029	0.00085	CcSEcCtD
Levonorgestrel—Dermatitis—Mometasone—systemic scleroderma	0.00029	0.00085	CcSEcCtD
Levonorgestrel—Decreased appetite—Leflunomide—systemic scleroderma	0.00029	0.000849	CcSEcCtD
Levonorgestrel—Musculoskeletal discomfort—Mycophenolic acid—systemic scleroderma	0.00029	0.000849	CcSEcCtD
Levonorgestrel—Gastrointestinal pain—Azathioprine—systemic scleroderma	0.000289	0.000846	CcSEcCtD
Levonorgestrel—Headache—Mometasone—systemic scleroderma	0.000288	0.000845	CcSEcCtD
Levonorgestrel—Gastrointestinal disorder—Leflunomide—systemic scleroderma	0.000288	0.000843	CcSEcCtD
Levonorgestrel—Insomnia—Mycophenolic acid—systemic scleroderma	0.000288	0.000843	CcSEcCtD
Levonorgestrel—Fatigue—Leflunomide—systemic scleroderma	0.000287	0.000842	CcSEcCtD
Levonorgestrel—Oedema—Lisinopril—systemic scleroderma	0.000286	0.000839	CcSEcCtD
Levonorgestrel—Pruritus—Captopril—systemic scleroderma	0.000286	0.000839	CcSEcCtD
Levonorgestrel—Constipation—Leflunomide—systemic scleroderma	0.000285	0.000835	CcSEcCtD
Levonorgestrel—Pain—Leflunomide—systemic scleroderma	0.000285	0.000835	CcSEcCtD
Levonorgestrel—Infection—Lisinopril—systemic scleroderma	0.000285	0.000834	CcSEcCtD
Levonorgestrel—Anaemia—Mycophenolate mofetil—systemic scleroderma	0.000284	0.000833	CcSEcCtD
Levonorgestrel—Dyspnoea—Mycophenolic acid—systemic scleroderma	0.000283	0.000831	CcSEcCtD
Levonorgestrel—Somnolence—Mycophenolic acid—systemic scleroderma	0.000283	0.000829	CcSEcCtD
Levonorgestrel—Shock—Lisinopril—systemic scleroderma	0.000282	0.000826	CcSEcCtD
Levonorgestrel—Angioedema—Mycophenolate mofetil—systemic scleroderma	0.000281	0.000823	CcSEcCtD
Levonorgestrel—Dyspepsia—Mycophenolic acid—systemic scleroderma	0.00028	0.00082	CcSEcCtD
Levonorgestrel—Abdominal pain—Azathioprine—systemic scleroderma	0.000279	0.000818	CcSEcCtD
Levonorgestrel—Body temperature increased—Azathioprine—systemic scleroderma	0.000279	0.000818	CcSEcCtD
Levonorgestrel—Skin disorder—Lisinopril—systemic scleroderma	0.000278	0.000815	CcSEcCtD
Levonorgestrel—Hyperhidrosis—Lisinopril—systemic scleroderma	0.000277	0.000812	CcSEcCtD
Levonorgestrel—Diarrhoea—Captopril—systemic scleroderma	0.000277	0.000811	CcSEcCtD
Levonorgestrel—Decreased appetite—Mycophenolic acid—systemic scleroderma	0.000276	0.00081	CcSEcCtD
Levonorgestrel—Vertigo—Mycophenolate mofetil—systemic scleroderma	0.000276	0.00081	CcSEcCtD
Levonorgestrel—Syncope—Mycophenolate mofetil—systemic scleroderma	0.000276	0.000808	CcSEcCtD
Levonorgestrel—Gastrointestinal disorder—Mycophenolic acid—systemic scleroderma	0.000275	0.000805	CcSEcCtD
Levonorgestrel—Fatigue—Mycophenolic acid—systemic scleroderma	0.000274	0.000804	CcSEcCtD
Levonorgestrel—Mood swings—Methotrexate—systemic scleroderma	0.000274	0.000803	CcSEcCtD
Levonorgestrel—Nausea—Mometasone—systemic scleroderma	0.000273	0.000802	CcSEcCtD
Levonorgestrel—Anorexia—Lisinopril—systemic scleroderma	0.000273	0.0008	CcSEcCtD
Levonorgestrel—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.000273	0.000799	CcSEcCtD
Levonorgestrel—Weight increased—Prednisone—systemic scleroderma	0.000272	0.000798	CcSEcCtD
Levonorgestrel—Constipation—Mycophenolic acid—systemic scleroderma	0.000272	0.000797	CcSEcCtD
Levonorgestrel—Pain—Mycophenolic acid—systemic scleroderma	0.000272	0.000797	CcSEcCtD
Levonorgestrel—Palpitations—Mycophenolate mofetil—systemic scleroderma	0.000272	0.000796	CcSEcCtD
Levonorgestrel—Weight decreased—Prednisone—systemic scleroderma	0.000271	0.000793	CcSEcCtD
Levonorgestrel—Loss of consciousness—Mycophenolate mofetil—systemic scleroderma	0.00027	0.000792	CcSEcCtD
Levonorgestrel—Cough—Mycophenolate mofetil—systemic scleroderma	0.000268	0.000786	CcSEcCtD
Levonorgestrel—Dizziness—Captopril—systemic scleroderma	0.000267	0.000784	CcSEcCtD
Levonorgestrel—Depression—Prednisone—systemic scleroderma	0.000266	0.000779	CcSEcCtD
Levonorgestrel—Hypertension—Mycophenolate mofetil—systemic scleroderma	0.000265	0.000778	CcSEcCtD
Levonorgestrel—Urticaria—Leflunomide—systemic scleroderma	0.000265	0.000776	CcSEcCtD
Levonorgestrel—Body temperature increased—Leflunomide—systemic scleroderma	0.000263	0.000772	CcSEcCtD
Levonorgestrel—Abdominal pain—Leflunomide—systemic scleroderma	0.000263	0.000772	CcSEcCtD
Levonorgestrel—Chest pain—Mycophenolate mofetil—systemic scleroderma	0.000262	0.000767	CcSEcCtD
Levonorgestrel—Myalgia—Mycophenolate mofetil—systemic scleroderma	0.000262	0.000767	CcSEcCtD
Levonorgestrel—Breast disorder—Methotrexate—systemic scleroderma	0.000261	0.000766	CcSEcCtD
Levonorgestrel—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.000261	0.000765	CcSEcCtD
Levonorgestrel—Anxiety—Mycophenolate mofetil—systemic scleroderma	0.000261	0.000765	CcSEcCtD
Levonorgestrel—Hypersensitivity—Azathioprine—systemic scleroderma	0.00026	0.000762	CcSEcCtD
Levonorgestrel—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.00026	0.000762	CcSEcCtD
Levonorgestrel—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic scleroderma	0.00026	0.000762	CcSEcCtD
Levonorgestrel—Insomnia—Lisinopril—systemic scleroderma	0.000259	0.000759	CcSEcCtD
Levonorgestrel—Discomfort—Mycophenolate mofetil—systemic scleroderma	0.000259	0.000758	CcSEcCtD
Levonorgestrel—Vomiting—Captopril—systemic scleroderma	0.000257	0.000754	CcSEcCtD
Levonorgestrel—Dyspnoea—Lisinopril—systemic scleroderma	0.000255	0.000748	CcSEcCtD
Levonorgestrel—Rash—Captopril—systemic scleroderma	0.000255	0.000747	CcSEcCtD
Levonorgestrel—Dermatitis—Captopril—systemic scleroderma	0.000255	0.000747	CcSEcCtD
Levonorgestrel—Somnolence—Lisinopril—systemic scleroderma	0.000255	0.000746	CcSEcCtD
Levonorgestrel—Headache—Captopril—systemic scleroderma	0.000253	0.000743	CcSEcCtD
Levonorgestrel—Dyspepsia—Lisinopril—systemic scleroderma	0.000252	0.000739	CcSEcCtD
Levonorgestrel—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.000251	0.000737	CcSEcCtD
Levonorgestrel—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.000251	0.000737	CcSEcCtD
Levonorgestrel—Oedema—Mycophenolate mofetil—systemic scleroderma	0.000251	0.000736	CcSEcCtD
Levonorgestrel—Asthma—Methotrexate—systemic scleroderma	0.00025	0.000733	CcSEcCtD
Levonorgestrel—Infection—Mycophenolate mofetil—systemic scleroderma	0.000249	0.000731	CcSEcCtD
Levonorgestrel—Decreased appetite—Lisinopril—systemic scleroderma	0.000249	0.00073	CcSEcCtD
Levonorgestrel—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.000247	0.000725	CcSEcCtD
Levonorgestrel—Fatigue—Lisinopril—systemic scleroderma	0.000247	0.000724	CcSEcCtD
Levonorgestrel—Shock—Mycophenolate mofetil—systemic scleroderma	0.000247	0.000724	CcSEcCtD
Levonorgestrel—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	0.000246	0.000721	CcSEcCtD
Levonorgestrel—Hypersensitivity—Leflunomide—systemic scleroderma	0.000246	0.00072	CcSEcCtD
Levonorgestrel—Constipation—Lisinopril—systemic scleroderma	0.000245	0.000718	CcSEcCtD
Levonorgestrel—Pain—Lisinopril—systemic scleroderma	0.000245	0.000718	CcSEcCtD
Levonorgestrel—Skin disorder—Mycophenolate mofetil—systemic scleroderma	0.000244	0.000714	CcSEcCtD
Levonorgestrel—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	0.000243	0.000711	CcSEcCtD
Levonorgestrel—Diarrhoea—Azathioprine—systemic scleroderma	0.000241	0.000708	CcSEcCtD
Levonorgestrel—Haemoglobin—Prednisone—systemic scleroderma	0.000241	0.000705	CcSEcCtD
Levonorgestrel—Nausea—Captopril—systemic scleroderma	0.00024	0.000704	CcSEcCtD
Levonorgestrel—Haemorrhage—Prednisone—systemic scleroderma	0.000239	0.000702	CcSEcCtD
Levonorgestrel—Anorexia—Mycophenolate mofetil—systemic scleroderma	0.000239	0.000701	CcSEcCtD
Levonorgestrel—Asthenia—Leflunomide—systemic scleroderma	0.000239	0.000701	CcSEcCtD
Levonorgestrel—Pruritus—Leflunomide—systemic scleroderma	0.000236	0.000691	CcSEcCtD
Levonorgestrel—Connective tissue disorder—Prednisone—systemic scleroderma	0.000235	0.00069	CcSEcCtD
Levonorgestrel—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.000234	0.000686	CcSEcCtD
Levonorgestrel—Dysuria—Methotrexate—systemic scleroderma	0.000234	0.000685	CcSEcCtD
Levonorgestrel—Dizziness—Azathioprine—systemic scleroderma	0.000233	0.000684	CcSEcCtD
Levonorgestrel—Upper respiratory tract infection—Methotrexate—systemic scleroderma	0.000232	0.000681	CcSEcCtD
Levonorgestrel—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.000229	0.00067	CcSEcCtD
Levonorgestrel—Asthenia—Mycophenolic acid—systemic scleroderma	0.000228	0.000669	CcSEcCtD
Levonorgestrel—Diarrhoea—Leflunomide—systemic scleroderma	0.000228	0.000668	CcSEcCtD
Levonorgestrel—Urticaria—Lisinopril—systemic scleroderma	0.000228	0.000667	CcSEcCtD
Levonorgestrel—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.000227	0.000665	CcSEcCtD
Levonorgestrel—Abdominal pain—Lisinopril—systemic scleroderma	0.000226	0.000664	CcSEcCtD
Levonorgestrel—Body temperature increased—Lisinopril—systemic scleroderma	0.000226	0.000664	CcSEcCtD
Levonorgestrel—Pruritus—Mycophenolic acid—systemic scleroderma	0.000225	0.000659	CcSEcCtD
Levonorgestrel—Vomiting—Azathioprine—systemic scleroderma	0.000224	0.000658	CcSEcCtD
Levonorgestrel—Pneumonia—Methotrexate—systemic scleroderma	0.000224	0.000657	CcSEcCtD
Levonorgestrel—Eye disorder—Prednisone—systemic scleroderma	0.000224	0.000656	CcSEcCtD
Levonorgestrel—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.000224	0.000656	CcSEcCtD
Levonorgestrel—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.000223	0.000654	CcSEcCtD
Levonorgestrel—Infestation NOS—Methotrexate—systemic scleroderma	0.000223	0.000653	CcSEcCtD
Levonorgestrel—Infestation—Methotrexate—systemic scleroderma	0.000223	0.000653	CcSEcCtD
Levonorgestrel—Rash—Azathioprine—systemic scleroderma	0.000223	0.000652	CcSEcCtD
Levonorgestrel—Dermatitis—Azathioprine—systemic scleroderma	0.000222	0.000652	CcSEcCtD
Levonorgestrel—Depression—Methotrexate—systemic scleroderma	0.000222	0.000651	CcSEcCtD
Levonorgestrel—Headache—Azathioprine—systemic scleroderma	0.000221	0.000648	CcSEcCtD
Levonorgestrel—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.000221	0.000647	CcSEcCtD
Levonorgestrel—Dizziness—Leflunomide—systemic scleroderma	0.00022	0.000646	CcSEcCtD
Levonorgestrel—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.000218	0.000639	CcSEcCtD
Levonorgestrel—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000218	0.000638	CcSEcCtD
Levonorgestrel—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.000217	0.000635	CcSEcCtD
Levonorgestrel—Immune system disorder—Prednisone—systemic scleroderma	0.000216	0.000634	CcSEcCtD
Levonorgestrel—Constipation—Mycophenolate mofetil—systemic scleroderma	0.000215	0.000629	CcSEcCtD
Levonorgestrel—Pain—Mycophenolate mofetil—systemic scleroderma	0.000215	0.000629	CcSEcCtD
Levonorgestrel—Arrhythmia—Prednisone—systemic scleroderma	0.000214	0.000627	CcSEcCtD
Levonorgestrel—Vomiting—Leflunomide—systemic scleroderma	0.000212	0.000621	CcSEcCtD
Levonorgestrel—Alopecia—Prednisone—systemic scleroderma	0.000212	0.00062	CcSEcCtD
Levonorgestrel—Hypersensitivity—Lisinopril—systemic scleroderma	0.000211	0.000618	CcSEcCtD
Levonorgestrel—Dizziness—Mycophenolic acid—systemic scleroderma	0.00021	0.000616	CcSEcCtD
Levonorgestrel—Rash—Leflunomide—systemic scleroderma	0.00021	0.000616	CcSEcCtD
Levonorgestrel—Dermatitis—Leflunomide—systemic scleroderma	0.00021	0.000615	CcSEcCtD
Levonorgestrel—Mental disorder—Prednisone—systemic scleroderma	0.00021	0.000615	CcSEcCtD
Levonorgestrel—Nausea—Azathioprine—systemic scleroderma	0.00021	0.000614	CcSEcCtD
Levonorgestrel—Headache—Leflunomide—systemic scleroderma	0.000209	0.000612	CcSEcCtD
Levonorgestrel—Malnutrition—Prednisone—systemic scleroderma	0.000208	0.000611	CcSEcCtD
Levonorgestrel—Erythema—Prednisone—systemic scleroderma	0.000208	0.000611	CcSEcCtD
Levonorgestrel—Asthenia—Lisinopril—systemic scleroderma	0.000205	0.000602	CcSEcCtD
Levonorgestrel—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.000205	0.000601	CcSEcCtD
Levonorgestrel—Pruritus—Lisinopril—systemic scleroderma	0.000203	0.000594	CcSEcCtD
Levonorgestrel—Vomiting—Mycophenolic acid—systemic scleroderma	0.000202	0.000593	CcSEcCtD
Levonorgestrel—Haemoglobin—Methotrexate—systemic scleroderma	0.000201	0.000589	CcSEcCtD
Levonorgestrel—Rash—Mycophenolic acid—systemic scleroderma	0.0002	0.000588	CcSEcCtD
Levonorgestrel—Dermatitis—Mycophenolic acid—systemic scleroderma	0.0002	0.000587	CcSEcCtD
Levonorgestrel—Haemorrhage—Methotrexate—systemic scleroderma	0.0002	0.000586	CcSEcCtD
Levonorgestrel—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.000199	0.000584	CcSEcCtD
Levonorgestrel—Headache—Mycophenolic acid—systemic scleroderma	0.000199	0.000584	CcSEcCtD
Levonorgestrel—Pharyngitis—Methotrexate—systemic scleroderma	0.000199	0.000582	CcSEcCtD
Levonorgestrel—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.000198	0.000581	CcSEcCtD
Levonorgestrel—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.000198	0.000581	CcSEcCtD
Levonorgestrel—Nausea—Leflunomide—systemic scleroderma	0.000198	0.00058	CcSEcCtD
Levonorgestrel—Urinary tract disorder—Methotrexate—systemic scleroderma	0.000198	0.000579	CcSEcCtD
Levonorgestrel—Urethral disorder—Methotrexate—systemic scleroderma	0.000196	0.000575	CcSEcCtD
Levonorgestrel—Diarrhoea—Lisinopril—systemic scleroderma	0.000196	0.000574	CcSEcCtD
Levonorgestrel—Visual impairment—Methotrexate—systemic scleroderma	0.000193	0.000565	CcSEcCtD
Levonorgestrel—Anaemia—Prednisone—systemic scleroderma	0.000193	0.000565	CcSEcCtD
Levonorgestrel—Angioedema—Prednisone—systemic scleroderma	0.00019	0.000558	CcSEcCtD
Levonorgestrel—Dizziness—Lisinopril—systemic scleroderma	0.000189	0.000555	CcSEcCtD
Levonorgestrel—Erythema multiforme—Methotrexate—systemic scleroderma	0.000189	0.000555	CcSEcCtD
Levonorgestrel—Nausea—Mycophenolic acid—systemic scleroderma	0.000189	0.000554	CcSEcCtD
Levonorgestrel—Vertigo—Prednisone—systemic scleroderma	0.000187	0.000549	CcSEcCtD
Levonorgestrel—Eye disorder—Methotrexate—systemic scleroderma	0.000187	0.000548	CcSEcCtD
Levonorgestrel—Syncope—Prednisone—systemic scleroderma	0.000187	0.000548	CcSEcCtD
Levonorgestrel—Cardiac disorder—Methotrexate—systemic scleroderma	0.000186	0.000544	CcSEcCtD
Levonorgestrel—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.000185	0.000542	CcSEcCtD
Levonorgestrel—Loss of consciousness—Prednisone—systemic scleroderma	0.000183	0.000537	CcSEcCtD
Levonorgestrel—Vomiting—Lisinopril—systemic scleroderma	0.000182	0.000534	CcSEcCtD
Levonorgestrel—Immune system disorder—Methotrexate—systemic scleroderma	0.000181	0.00053	CcSEcCtD
Levonorgestrel—Rash—Lisinopril—systemic scleroderma	0.000181	0.000529	CcSEcCtD
Levonorgestrel—Dermatitis—Lisinopril—systemic scleroderma	0.00018	0.000529	CcSEcCtD
Levonorgestrel—Mediastinal disorder—Methotrexate—systemic scleroderma	0.00018	0.000529	CcSEcCtD
Levonorgestrel—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.00018	0.000528	CcSEcCtD
Levonorgestrel—Hypertension—Prednisone—systemic scleroderma	0.00018	0.000527	CcSEcCtD
Levonorgestrel—Headache—Lisinopril—systemic scleroderma	0.000179	0.000526	CcSEcCtD
Levonorgestrel—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000178	0.00052	CcSEcCtD
Levonorgestrel—Myalgia—Prednisone—systemic scleroderma	0.000177	0.00052	CcSEcCtD
Levonorgestrel—Anxiety—Prednisone—systemic scleroderma	0.000177	0.000518	CcSEcCtD
Levonorgestrel—Alopecia—Methotrexate—systemic scleroderma	0.000177	0.000518	CcSEcCtD
Levonorgestrel—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic scleroderma	0.000176	0.000516	CcSEcCtD
Levonorgestrel—Discomfort—Prednisone—systemic scleroderma	0.000175	0.000514	CcSEcCtD
Levonorgestrel—Mental disorder—Methotrexate—systemic scleroderma	0.000175	0.000514	CcSEcCtD
Levonorgestrel—Erythema—Methotrexate—systemic scleroderma	0.000174	0.000511	CcSEcCtD
Levonorgestrel—Malnutrition—Methotrexate—systemic scleroderma	0.000174	0.000511	CcSEcCtD
Levonorgestrel—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000172	0.000503	CcSEcCtD
Levonorgestrel—Nausea—Lisinopril—systemic scleroderma	0.00017	0.000499	CcSEcCtD
Levonorgestrel—Oedema—Prednisone—systemic scleroderma	0.00017	0.000499	CcSEcCtD
Levonorgestrel—Infection—Prednisone—systemic scleroderma	0.000169	0.000495	CcSEcCtD
Levonorgestrel—Back pain—Methotrexate—systemic scleroderma	0.000168	0.000494	CcSEcCtD
Levonorgestrel—Shock—Prednisone—systemic scleroderma	0.000167	0.000491	CcSEcCtD
Levonorgestrel—Nervous system disorder—Prednisone—systemic scleroderma	0.000167	0.000489	CcSEcCtD
Levonorgestrel—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000166	0.000486	CcSEcCtD
Levonorgestrel—Skin disorder—Prednisone—systemic scleroderma	0.000165	0.000484	CcSEcCtD
Levonorgestrel—Hyperhidrosis—Prednisone—systemic scleroderma	0.000164	0.000482	CcSEcCtD
Levonorgestrel—Anorexia—Prednisone—systemic scleroderma	0.000162	0.000475	CcSEcCtD
Levonorgestrel—Anaemia—Methotrexate—systemic scleroderma	0.000161	0.000472	CcSEcCtD
Levonorgestrel—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.00016	0.000468	CcSEcCtD
Levonorgestrel—Rash—Mycophenolate mofetil—systemic scleroderma	0.000158	0.000464	CcSEcCtD
Levonorgestrel—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000158	0.000463	CcSEcCtD
Levonorgestrel—Headache—Mycophenolate mofetil—systemic scleroderma	0.000157	0.000461	CcSEcCtD
Levonorgestrel—Vertigo—Methotrexate—systemic scleroderma	0.000156	0.000459	CcSEcCtD
Levonorgestrel—Musculoskeletal discomfort—Prednisone—systemic scleroderma	0.000155	0.000454	CcSEcCtD
Levonorgestrel—Insomnia—Prednisone—systemic scleroderma	0.000154	0.000451	CcSEcCtD
Levonorgestrel—Cough—Methotrexate—systemic scleroderma	0.000152	0.000445	CcSEcCtD
Levonorgestrel—Dyspepsia—Prednisone—systemic scleroderma	0.00015	0.000439	CcSEcCtD
Levonorgestrel—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000149	0.000437	CcSEcCtD
Levonorgestrel—Chest pain—Methotrexate—systemic scleroderma	0.000148	0.000435	CcSEcCtD
Levonorgestrel—Myalgia—Methotrexate—systemic scleroderma	0.000148	0.000435	CcSEcCtD
Levonorgestrel—Decreased appetite—Prednisone—systemic scleroderma	0.000148	0.000433	CcSEcCtD
Levonorgestrel—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic scleroderma	0.000147	0.000432	CcSEcCtD
Levonorgestrel—Fatigue—Prednisone—systemic scleroderma	0.000147	0.00043	CcSEcCtD
Levonorgestrel—Discomfort—Methotrexate—systemic scleroderma	0.000147	0.000429	CcSEcCtD
Levonorgestrel—Constipation—Prednisone—systemic scleroderma	0.000145	0.000426	CcSEcCtD
Levonorgestrel—Infection—Methotrexate—systemic scleroderma	0.000141	0.000414	CcSEcCtD
Levonorgestrel—Nervous system disorder—Methotrexate—systemic scleroderma	0.000139	0.000409	CcSEcCtD
Levonorgestrel—Gastrointestinal pain—Prednisone—systemic scleroderma	0.000139	0.000408	CcSEcCtD
Levonorgestrel—Skin disorder—Methotrexate—systemic scleroderma	0.000138	0.000405	CcSEcCtD
Levonorgestrel—Hyperhidrosis—Methotrexate—systemic scleroderma	0.000137	0.000403	CcSEcCtD
Levonorgestrel—Anorexia—Methotrexate—systemic scleroderma	0.000135	0.000397	CcSEcCtD
Levonorgestrel—Urticaria—Prednisone—systemic scleroderma	0.000135	0.000396	CcSEcCtD
Levonorgestrel—Body temperature increased—Prednisone—systemic scleroderma	0.000134	0.000394	CcSEcCtD
Levonorgestrel—Abdominal pain—Prednisone—systemic scleroderma	0.000134	0.000394	CcSEcCtD
Levonorgestrel—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	0.00013	0.00038	CcSEcCtD
Levonorgestrel—Insomnia—Methotrexate—systemic scleroderma	0.000129	0.000377	CcSEcCtD
Levonorgestrel—Dyspnoea—Methotrexate—systemic scleroderma	0.000127	0.000371	CcSEcCtD
Levonorgestrel—Somnolence—Methotrexate—systemic scleroderma	0.000126	0.00037	CcSEcCtD
Levonorgestrel—Hypersensitivity—Prednisone—systemic scleroderma	0.000125	0.000367	CcSEcCtD
Levonorgestrel—Dyspepsia—Methotrexate—systemic scleroderma	0.000125	0.000367	CcSEcCtD
Levonorgestrel—Decreased appetite—Methotrexate—systemic scleroderma	0.000124	0.000362	CcSEcCtD
Levonorgestrel—Gastrointestinal disorder—Methotrexate—systemic scleroderma	0.000123	0.00036	CcSEcCtD
Levonorgestrel—Fatigue—Methotrexate—systemic scleroderma	0.000123	0.000359	CcSEcCtD
Levonorgestrel—Asthenia—Prednisone—systemic scleroderma	0.000122	0.000358	CcSEcCtD
Levonorgestrel—Pain—Methotrexate—systemic scleroderma	0.000122	0.000356	CcSEcCtD
Levonorgestrel—Pruritus—Prednisone—systemic scleroderma	0.00012	0.000353	CcSEcCtD
Levonorgestrel—Diarrhoea—Prednisone—systemic scleroderma	0.000116	0.000341	CcSEcCtD
Levonorgestrel—Gastrointestinal pain—Methotrexate—systemic scleroderma	0.000116	0.000341	CcSEcCtD
Levonorgestrel—Urticaria—Methotrexate—systemic scleroderma	0.000113	0.000331	CcSEcCtD
Levonorgestrel—Dizziness—Prednisone—systemic scleroderma	0.000112	0.00033	CcSEcCtD
Levonorgestrel—Body temperature increased—Methotrexate—systemic scleroderma	0.000112	0.000329	CcSEcCtD
Levonorgestrel—Abdominal pain—Methotrexate—systemic scleroderma	0.000112	0.000329	CcSEcCtD
Levonorgestrel—Vomiting—Prednisone—systemic scleroderma	0.000108	0.000317	CcSEcCtD
Levonorgestrel—Rash—Prednisone—systemic scleroderma	0.000107	0.000314	CcSEcCtD
Levonorgestrel—Dermatitis—Prednisone—systemic scleroderma	0.000107	0.000314	CcSEcCtD
Levonorgestrel—Headache—Prednisone—systemic scleroderma	0.000107	0.000312	CcSEcCtD
Levonorgestrel—Hypersensitivity—Methotrexate—systemic scleroderma	0.000105	0.000307	CcSEcCtD
Levonorgestrel—Asthenia—Methotrexate—systemic scleroderma	0.000102	0.000299	CcSEcCtD
Levonorgestrel—Nausea—Prednisone—systemic scleroderma	0.000101	0.000296	CcSEcCtD
Levonorgestrel—Pruritus—Methotrexate—systemic scleroderma	0.000101	0.000295	CcSEcCtD
Levonorgestrel—Diarrhoea—Methotrexate—systemic scleroderma	9.73e-05	0.000285	CcSEcCtD
Levonorgestrel—Dizziness—Methotrexate—systemic scleroderma	9.4e-05	0.000276	CcSEcCtD
Levonorgestrel—Vomiting—Methotrexate—systemic scleroderma	9.04e-05	0.000265	CcSEcCtD
Levonorgestrel—Rash—Methotrexate—systemic scleroderma	8.96e-05	0.000263	CcSEcCtD
Levonorgestrel—Dermatitis—Methotrexate—systemic scleroderma	8.95e-05	0.000262	CcSEcCtD
Levonorgestrel—Headache—Methotrexate—systemic scleroderma	8.91e-05	0.000261	CcSEcCtD
Levonorgestrel—Nausea—Methotrexate—systemic scleroderma	8.44e-05	0.000247	CcSEcCtD
